Information Library
Results for: Consulting - Late Phase
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Understanding the Complexity of HTA Networks
Presentation — November 27, 2011
As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Names New Global Head of Clinical & Data Operations
Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.
-
Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage
Press Release — September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.
-
How Informative is Your Segmentation?
Hear from the Experts — September 15, 2011
Article published by Quintiles' Pieter Sheth-Voss in the Winter 2010 issue of Market Research magazine was recently awarded the David K. Hardin Memorial Award for 2011. -
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
Leveraging social networks to conduct observational research
Presentation — March 26, 2011
Quintiles’ presentation describes the benefits of social networks in terms of patient identification, cost and time, relative to traditional observational research approaches. -
Late Phase Research
Brochure — March 14, 2011
Integrated solutions to define, demonstrate and communicate product value -
The Use of Large Simple Trials
Presentation — February 25, 2011
Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data. -
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling.
